The Problem With Composite End Points in Cardiovascular Studies

Kip, Kevin E., Hollabaugh, Kim, Marroquin, Oscar C., Williams, David O.·2008·Journal of the American College of Cardiology

Cited by (348)

Items 301–348 of 348

  1. Multiple Outcomes in Heart Failure Research: Composite Endpoints and Multivariate Modelling
    Paul M. Brown · 2017 · ERA: Education and Research Archive (University of Alberta)
  2. In Reply:
    Shannon M. Fernando, Alexandre Tran, Wei Cheng, Bram N. Rochwerg, Monica Taljaard, Venkatesh Thiruganasambandamoorthy, Kwadwo Kyeremanteng, Jeffrey Joseph Perry · 2019 · Academic Emergency Medicine
  3. Clinical outcomes of automated anastomotic devices: A metanalysis
    Linda Renata Micali, Francesco Matteucci, Orlando Parise, Cecilia Tetta, Amalia Ioanna Moula, Monique M.J. de Jong, Francesco Londero, Sandro Gelsomino · 2019 · Journal of Cardiac Surgery
  4. Reply
    Edward A Hulten, Sara P. Petrillo, Todd C. Villines · 2011 · Journal of the American College of Cardiology
  5. Ticagrelor Versus Clopidogrel in ST Segment Elevation Myocardial Infarction Patients Candidate for Primary Percutaneous Coronary Intervention
    Hassan Ebeid, H M Rasmy Mohamed, Khaled Elkhashab, Mohamed Abdulaziz Aljarallah, Mai Magedi Abdo, Ahmed Tharwat Dabees, Ibrahim Mahmoud Elkhouly, Haytham Soliman Ghareeb · 2021 · Indian Journal of Clinical Cardiology
  6. Mediators in cardiovascular disease: association with Raynaud’s phenomenon
    Amaal Eman Abdulle · 2021
  7. Forum
    2008 · Pharmaceutical Medicine
  8. Major adverse cardiovascular events after implantation of absorb bioresorbable scaffold: One-year clinical outcomes
    Tanja Šobot, Nikola Šobot, Zorislava Bajić, Nenad Ponorac, Rade Babić · 2021 · Scripta Medica
  9. Coronary Event
    Siqin Ye · 2020 · Springer eBooks
  10. Cardiac Events
    Siqin Ye · 2020 · Springer eBooks
  11. Peer Review #1 of "Accuracy of triggering receptor expressed on myeloid cells 1 in diagnosis and prognosis of acute myocardial infarction: a prospective cohort study (v0.1)"
    2021 · PeerJ
  12. Peer Review #2 of "Accuracy of triggering receptor expressed on myeloid cells 1 in diagnosis and prognosis of acute myocardial infarction: a prospective cohort study (v0.1)"
    2021 · PeerJ
  13. Peer Review #1 of "Accuracy of triggering receptor expressed on myeloid cells 1 in diagnosis and prognosis of acute myocardial infarction: a prospective cohort study (v0.2)"
    2021 · PeerJ
  14. Major adverse cardiovascular event
    Joachim Feger, Rohit Sharma, Francesco Sciacca · 2020 · Radiopaedia.org
  15. Coronary Event
    Siqin Ye · 2018 · Springer eBooks
  16. In Reply:
    Jason P. Stopyra, Chadwick D. Miller, Simon A. Mahler · 2017 · Academic Emergency Medicine
  17. Cardiac Events
    Siqin Ye · 2018 · Springer eBooks
  18. Meaningful outcome measurements
    Travis William McCain Pebror · 2023 · Elsevier eBooks
  19. Shockwave Intravascular Lithotripsy: The Future of Coronary Intervention?
    E. Thirumurugan, K. Gomathi, R. Karthick · 2023 · Research in Cardiovascular Medicine
  20. Patient‐Centered Rocket Science: Accurate but Imprecise
    Jeffrey Alexander Bakal, David J. Wilber · 2024 · Journal of the American Heart Association
  21. The effect of coronary revascularization timing on cardiovascular outcomes in patients with ischemic heart disease
    Sean Hardiman, Guy J. Fradet, Lisa Kuramoto, Michael R. Law, Simon D. Robinson, Boris G. Sobolev · 2024 · medRxiv
  22. Comparison of Small Blood Vessel Diameter with Intravascular Ultrasound and Coronary Angiography for Guidance of Percutaneous Coronary Intervention
    Sergio A. Zuñiga-Mendoza, Emanuel Zayas-Diaz, Victoria del Rosario Armenta-Velazquez, Ana Aurora Silva-Baeza, Juan Jorge Beltran-Ochoa, Misael A. Medina-Servin, Maria Guadalupe Zavala-Cerna · 2024 · Diagnostics
  23. Pharmacovigilance and Pharmacoepidemiology: Public Health and Safety
    2024 · Frontiers research topics
  24. Traditional Chinese medicine for male sexual dysfunction and the risk of major adverse cardiovascular events: A population-based retrospective cohort study
    Wen‐Chieh Yang, Heng-Jun Lin · 2024 · Research Square
  25. Machine learning approach for detection of MACE events within clinical trial data
    John A. Spanias, Robbie Buderi, Pierre-Louis Bourlon, Christopher Tso, Caleb E. Strait, David Saunders, Kayleen Deanna Ports, Weixi Chen, Rahul Jain, Bhargav Koduru et al. · 2024 · Journal of Biopharmaceutical Statistics
  26. Preoperative risk factors for cardiovascular events in non-cardiac surgery
    S. S. Murashko, Svetlana A. Berns, И. Н. Пасечник · 2024 · CARDIOVASCULAR THERAPY AND PREVENTION
  27. Developing a multi-label learning model to predict major adverse cardiovascular events in patients with unstable angina pectoris: A prospective cohort study
    Jing Li, Hong Bo Yang, Yu Zhang, Jingjing Yan, Jingjing Yan, Yanbo Zhang · 2025 · International Journal of Medical Informatics
  28. Heterogeneity of Primary Outcomes in Large Percutaneous Coronary Intervention Trials Published in High-Impact Medical Journals
    Melissa A. Hynds, Danielle R. Rome, Ilan Richter, Emilia A. Hermann, Michael I. Brener, R. Graham Barr, Daniel Shepshelovich · 2025 · The American Journal of Cardiology
  29. Statin Treatment for Reducing Mortality Risk in Individuals over 75 Years of Age: A Large-Scale Retrospective Analysis
    Noy Nachmias, Sher Matsri, Maisaa Sharary, Noam Yaniv, Tal Netser, Assaf Buch, Yona Greenman, Elena Izkhakov, Eugene Feigin · 2025 · Journal of Clinical Medicine
  30. CCL17 as an Inflammatory Biomarker Enhances Cardiovascular Risk Stratification: a Prospective Cohort Study
    Zeyuan Wang, Xiaoyu Ren, Lu Yang, Jingli Yang, Jiabo Wu, Yan Zhang, Shuyang Zhang, Zhuang Tian, Shuyang Zhang · 2025 · Journal of Cardiovascular Translational Research
  31. Additional file 1 of Participation in disease management programs and major adverse cardiac events in patients after acute myocardial infarction: a longitudinal study based on registry data
    Christian Fischer, Jens Höpner, Saskia Hartwig, Noutsias, Michel, Mikolajczyk, Rafael · 2021 · Figshare
  32. Additional file 1 of Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights
    Josep Ramón Marsal, Iratxe Urreta, Marimar Ubeda, Dimelza Osorio, Blanca Lumbreras, Lora, David, Fernández-Felix, Borja M., Gerard Oristrell, Eduard Ródenas‐Alesina, Lorena Herrador et al. · 2023 · Figshare
  33. Additional file of Participation in disease management programs and major adverse cardiac events in patients after acute myocardial infarction: a longitudinal study based on registry data
    Christian Fischer, Jens Höpner, Saskia Hartwig, Noutsias, Michel, Mikolajczyk, Rafael · 2021 · Figshare
  34. Additional file 1 of SEA-MAKE score as a tool for predicting major adverse kidney events in critically ill patients with acute kidney injury: results from the SEA-AKI study
    Theerapon Sukmark, Nuttha Lumlertgul, Kearkiat Praditpornsilpa, Kriang Tungsanga, Somchai Eiam‐Ong, Srisawat, Nattachai · 2020 · Figshare
  35. Improved Coronary Microvascular Perfusion 8 Weeks After Acute Myocardial Infarction Is Associated with Improved Cardiovascular Prognosis: Insights from Myocardial Contrast Echocardiography
    Wuyi Zhan, Meijuan Lu, Xixuan Zhao, Weiwei Tao, Jiali Cao, Lingzhun Wang, Anxia He · 2025 · Ultrasound in Medicine & Biology
  36. Modification and empirical characterisation of the Lund Outcome Set for Evaluation of Triage
    André Johansson, Jakob Lundager Forberg, Anna Kristensson Ekwall, Ulf Ekelund · 2026 · Research Square
  37. Évaluation de la sénescence endothéliale et leucocytaire dans le choc septique
    Hamid Merdji · 2021 · theses.fr (ABES)
  38. Scores d’aide à la décision médicale et de recours aux investigations lors d’une suspicion d’accident cardiovasculaire aux urgences
    Thomas Moumneh · 2023 · theses.fr (ABES)
  39. Does unnecessary preoperative cardiac consultation and transthoracic echocardiogram delay time to surgery for geriatric hip fractures?
    Molly E. Milano, Richard J. D’Agostino · 2026 · Journal of Orthopaedic Reports
  40. Sociodemographic factors associated with major adverse cardiovascular events in the Ñuble Region in Chile: An ecological study
    Jacqueline Araneda, Jorge Celis-Dooner, Andrés Celis, Fanny Emily Petermann-Rocha · 2026 · Current Problems in Cardiology
  41. Modification and empirical characterisation of the Lund Outcome Set for Evaluation of Triage - a retrospective multicentre observational study
    André Johansson, Jakob Lundager Forberg, Anna Ekwall, Ulf Ekelund · 2026 · Research Square
  42. Безопасное сочетание каротидной эндартерэктомии и аортокоронарного шунтирования off-pump у пациентов с высоким риском сердечно-сосудистых осложнений
    Н.А.М.А. Дарвиш, V.Yu. Merzlyakov, В.Е. Иващенко, М.Ф. Есенеев, М.А. Шогенов, Р.Р. Валиева, А.С. Васильков, M.V. Shumilina · 2025 · Clinical Physiology of Circulation
  43. Prognostic value of total bilirubin level for patients suffering from coronary heart disease undergoing percutaneous coronary intervention: a meta-analysis
    Zhouxin Wu, Jinchuang Li, Jing Sun · 2026 · Frontiers in Cardiovascular Medicine
  44. Clarifying Divergent Mortality and MACE Findings With GLP‐1 RA–SGLT2i Combination Therapy
    Zhe Zhang, Suhua Xu · 2026 · Journal of Gastroenterology and Hepatology
  45. Understanding and interpreting composite outcomes in clinical research
    Mari Takashima, Brett Paul Dyer, Amanda Judith Ullman, Robert Stuart Ware · 2026 · Journal of Hospital Medicine
  46. A CRUSADE-adjusted prospective cohort analysis of heparin dosing velocity, multivariable mediation and iatrogenic haemorrhage in acute coronary syndromes
    Hasan Ali Farhan, Hussein AlKenzawi, Hayder Ali Majeed, Abbas Zuhair Marouf · 2026 · Romanian Journal of Cardiology
  47. Heterogeneity in MACE Definitions and Its Impact on Treatment Effect Estimates in Coronary Stent Trials: A Meta‐Epidemiological Study
    Xinyi Wang, Jianlan Yang, Youlin Long, Jiayu Ran, Siyuan Li, Zaichen Xu, Zixuan Jiang, Xingli Wan, Yao Li, Ke Fang et al. · 2026 · Journal of Evidence-Based Medicine
  48. Cardiovascular risk associated with first-line Janus kinase inhibitors versus TNF inhibitors in patients with RA: a nationwide cohort study
    Oh Chan Kwon, Hye Sun Lee, So Young Jeon, Min-Chan Park · 2026 · Rheumatology